Ramipril improves walking ability of PAD patients, study finds

02/6/2013 | HealthDay News

Researchers followed 212 people with peripheral artery disease and found that those who received the blood pressure drug ramipril walked 4 minutes longer on treadmill and got an extra 75 seconds of pain-free walking, on average, than those who took placebo. The improvement may sound relatively small but it surpasses the benefits of two FDA-approved drugs intended to improve PAD patients' walking ability, a researcher said. The findings were published in the Journal of the American Medical Association.

View Full Article in:

HealthDay News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD